Transgenic Mouse Overexpressing Syntaxin-1A as a Diabetes Model
Transgenic Mouse Overexpressing Syntaxin-1A as a Diabetes Model Patrick P.L. Lam 1 2 , Yuk-Man Leung 1 2 , Laura Sheu 1 2 , James Ellis 3 , Robert G. Tsushima 1 2 , Lucy R. Osborne 1 4 and Herbert Y. Gaisano 1 2 1 Department of Medicine, University of Toronto, Toronto, Canada 2 Department of Physiol...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 54; no. 9; pp. 2744 - 2754 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.09.2005
|
Subjects | |
Online Access | Get full text |
ISSN | 0012-1797 1939-327X |
DOI | 10.2337/diabetes.54.9.2744 |
Cover
Summary: | Transgenic Mouse Overexpressing Syntaxin-1A as a Diabetes Model
Patrick P.L. Lam 1 2 ,
Yuk-Man Leung 1 2 ,
Laura Sheu 1 2 ,
James Ellis 3 ,
Robert G. Tsushima 1 2 ,
Lucy R. Osborne 1 4 and
Herbert Y. Gaisano 1 2
1 Department of Medicine, University of Toronto, Toronto, Canada
2 Department of Physiology, University of Toronto, Toronto, Canada
3 Program in Developmental Biology, Sick Kids Hospital, Toronto, Canada
4 Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
Address correspondence and reprint requests to Herbert Y. Gaisano, MD, University of Toronto, Room 7226, Medical Science Building,
1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: herbert.gaisano{at}utoronto.ca . Or Lucy R. Osborne, PhD, University of Toronto, Room 7238, Medical Science Building, 1 King’s College Circle, Toronto, Ontario,
Canada M5S 1A8. E-mail: lucy.osborne{at}utoronto.ca
Abstract
Soluble N -ethylmaleimide–sensitive factor (NSF) attachment protein receptor (SNARE) protein syntaxin-1A (STX-1A) plays a role not only
in exocytosis, but also binds and regulates Ca 2+ and K + (voltage-gated K + and ATP-sensitive K + channels) to influence the sequence of events leading to secretion. Islet levels of STX-1A and cognate SNARE proteins are
reduced in type 2 diabetic rodents, suggesting their role in dysregulated insulin secretion contributing to the abnormal glucose
homeostasis. We investigated the specific role of STX-1A in pancreatic β-cells by generating transgenic mice, which express
a moderately increased level (∼30% higher) of STX-1A in pancreatic islets (hereafter called STX-1A mice). The STX-1A mice
displayed fasting hyperglycemia and a more sustained elevation of plasma glucose levels after an intraperitoneal glucose tolerance
test, with correspondingly reduced plasma insulin levels. Surprisingly, β-cells from the STX-1A male mice also exhibited abnormal
insulin tolerance. To unequivocally determine the β-cell secretory defects, we used single-cell analyses of exocytosis by
patch clamp membrane capacitance measurements and ion channel recordings. Depolarization-evoked membrane capacitance increases
were reduced in the STX-1A mouse islet β-cells. The STX-1A mouse also exhibited reduced currents through the Ca 2+ channels but little change in the voltage-gated K + channel or ATP-sensitive K + channel. These results suggest that fluctuation of islet STX-1A levels in diabetes could influence the pathological and differential
regulation of β-cell ion channels and the exocytotic machinery, collectively contributing to the impaired insulin secretion.
Cm, membrane capacitance
GST, glutathione S-transferase
IPGTT, intraperitoneal glucose tolerance test
KATP channel, ATP-sensitive K+ channel
Kv channel, voltage-gated potassium channel
NSF, N-ethylmaleimide–sensitive factor
SNAP-25, synaptosome-associated protein of 25 kDa
SNARE, soluble NSF attachment protein receptor
STX-1A, syntaxin-1A
TEA, tetraethylammonium
VAMP-2, vesicle-associated membrane protein 2
WBS, Williams-Beuren syndrome
Footnotes
P.P.L.L. and Y.-M.L. contributed equally to this work.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Accepted June 7, 2005.
Received November 23, 2004.
DIABETES |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.54.9.2744 |